Tubular overexpression of gremlin induces renal damage susceptibility in mice

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Droguett, Alejandra ^a   Krall, Paola ^a   Burgos, M Eugenia ^a   Valderrama, Graciela ^a   Carpio, Daniel ^a   Ardiles, Leopoldo ^a   Rodriguez Diez, Raquel ^c   Kerr, Bredford ^b   Walz, Katherina ^b   Ruiz Ortega, Marta ^c   Egido, Jesus ^c   Mezzano, Sergio ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b CENTRO DE ESTUDIOS CIENTÍFICOS CECS   (Chile)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANDROGEN; FOLIC ACID; TRANSFORMING GROWTH FACTOR BETA; GREM1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; EXPRESSION VECTOR; FEMALE; GENE; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; GREMLIN GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; LEYDIG CELL; LYMPHOCYTE; MACROPHAGE; MALE; MOLECULAR PATHOLOGY; MONOCYTE; MOUSE; NEPHROTOXICITY; NONHUMAN; PROMOTER REGION; PROTEINURIA; TRANSGENIC MOUSE; VALIDATION STUDY; WILD TYPE; ANIMAL; CELL LINE; DISEASE PREDISPOSITION; DRUG EFFECTS; GENE EXPRESSION; GENETICS; INJURIES; KIDNEY TUBULE; METABOLISM; PHENOTYPE;

ANIMALS; CELL LINE; DISEASE SUSCEPTIBILITY; FOLIC ACID; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TUBULES; MICE; MICE, TRANSGENIC; PHENOTYPE;

EID: 84904560447     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101879     Document Type: Article

References (35)

1. Topol LZ, Marx M, Laugier D, Bogdanova NN, Boubnov NV, et al. (1997) Identification of dmr, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol Cell Biol 17: 4801-4810. (Pubitemid 27318155)
2. Topol LZ, Bardot B, Zhang Q, Resau J, Huillard E, et al. (2000) Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 275: 8785-8793. (Pubitemid 30180233)
3. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM (1998) The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell1: 673-683. (Pubitemid 128379245)
4. Michos O, Panman L, Vintersten K, Beier K, Zeller R, et al. (2004) Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131: 3401-3410. (Pubitemid 39139886)
5. Roxburgh SA, Murphy M, Pollock CA, Brazil D (2006) Recapitulation of embryological programmes in renal fibrosis - the importance of epithelial cell plasticity and developmental genes. Nephron Physiol 103: 139-148.
6. McMahon R, Murphy M, Clarkson M, Taal M, Mackensie H, et al. (2000) IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem 275: 9901-9904. (Pubitemid 30202033)
7. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, et al. (1999) Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274: 5830-5834. (Pubitemid 29109239)
8. Lappin DW, McMahon R, Murphy M, Brady HR (2002) Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol Dial Transplant 17s9: 65-67.
9. Dolan V, Murphy M, Sadlier D, Lappin D, Doran P, et al. (2005) Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis 45: 1034-1039. (Pubitemid 40806516)
10. Mezzano S, Droguett A, Burgos ME, Aros C, Ardiles L, et al. (2007) Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis. Nephrol Dial Transplant 22: 1882-1890. (Pubitemid 47244756)
11. Carvajal G, Droguett A, Burgos ME, Aros C, Ardiles L, et al. (2008) Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy. Transplant Proc 40: 734-739. (Pubitemid 351608666)
12. Rodríguez Diez R, Lavoz C, Carvajal G, Rayego-Mateos S, Rodríguez Diez RR, et al. (2012) Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells. Nephron Exp Nephrol 122: 62-74.
13. Roxburgh SA, Kattla JJ, Curran SP, O'Meara YM, Pollock CA, et al. (2009) Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes 58: 1641-1650.
14. Zhang Q, Shi Y, Wada J, Malakauskas SM, Liu M, et al. (2010) In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7. PLoS One 5: e11709.
15. Farkas L, Farkas D, Gauldie J, Warburton D, Shi W, et al. (2011) Transient overexpression of Gremlin results in epithelial activation and reversible fibrosis in rat lungs. Am J Respir Cell Mol Biol 44: 870-878.
16. Ding Y, Davisson RL, Hardy DO, Zhu L, MerrilL DC, et al. (1997) The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 272: 28142-28148. (Pubitemid 27473625)
17. Ding Y, Sigmund C (2001) Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol 280: F54-F60.
18. Lavoie JL, Lake-Bruse KD, Sigmund CD (2004) Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol 286: F965-F971. (Pubitemid 38508997)
19. Sachetelli S, Liu Q, Zhang SL, Liu F, Hsieh TJ, et al. (2006) RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69: 1016-1023. (Pubitemid 43372176)
20. Li H, Zhou X, Davis DR, Xu D, Sigmund CD (2008) An androgen-inducible proximal tubule-specific Cre recombinase transgenic model. Am J Physiol Renal Physiol 294: F1481-F1486.
21. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
22. Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, et al. (2002) How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach. J Am Soc Nephrol 13: 2898-2908. (Pubitemid 35386909)
23. Ortega A, Rámila D, Ardura JA, Esteban V, Ruiz-Ortega M, et al. (2006) Role of parathyroid hormone-related protein in tubulointerstitial apoptosis and fibrosis after folic acid-induced nephrotoxicity. J Am Soc Nephrol 17: 1594-1603. (Pubitemid 43794662)
24. Phanish MK, Winn SK, Dockrell ME (2010) Connective tissue growth factor-(CTGF, CCN2)- a marker mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 114: e83-92.
25. Yokoi H, Mukoyama M, Mori K, Kasahara M, Suganami T, et al. (2008) Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int 73: 446-455. (Pubitemid 351186294)
26. Alfaro MP, Deskins DL, Wallus M, DasGupta J, Davidson JM, et al. (2013) A physiological role for connective tissue growth factor in early wound healing. Lab Invest 93: 81-95.
27. Bonniaud P, Margetts PJ, Kolb M, Haberberger T, Kelly M, et al. (2003) Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am J Respir Crit Care Med 168: 770-778. (Pubitemid 37188299)
28. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, et al. (1999) Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 181: 153-159. (Pubitemid 29400382)
29. Gentle ME, Shi S, Daehn I, Zhang T, Qi H, et al. (2013) Epithelial cell TGF-β signaling induces acute tubular injury and interstitial inflammation. J Am Soc Nephrol 24:787-799
30. Li G, Li Y, Liu S, Shi Y, Chi Y, et al. (2013) Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/Smad dependent signaling pathway. J Cell Biochem 114: 2101-2112.
31. Guimei M, Baddour N, Elkaffash D, Abdou L, Taher Y (2012) Gremlin in the pathogenesis of hepatocellular carcinoma complicating chronic hepatitis C: an immunohistochemical and PCR study of human liver biopsies. BMC Res Notes 5: 390.
32. Costello CM, Cahill E, Martin F, Gaine S, Mc Loughlin P (2010) Role of Gremlin in the lung: development and disease. Am J Respir Cell Mol Biol 42: 517-23.
33. Cahill E, Costello CM, Rowan SC, Harkin S, Howell K, et al. (2012) Gremlin plays a key role in the pathogenesis of pulmonary hypertension. Circulation 125: 920-930.
34. Koli K, Myllärniemi M, Vuorinen K, Salmenkivi K, Ryynänen MJ, et al. (2006) Bone morphogenetic protein-4 inhibitor gremlin is overexpressed in idiopathic pulmonary fibrosis. Am J Pathol 169: 61-71.
35. Karagiannis GS, Berk A, Dimitromanolakis A, Diamandis EP (2013) Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1. Mol Oncol7:826-839.